"The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease.Gaucher disease occurs in people who do not produce enough o"...
Experience with doses up to 240 U/kg every 2 weeks have been reported. At that dose there have been no reports of obvious toxicity.
There are no known contraindications to the use of Cerezyme® (imiglucerase for injection). Treatment with Cerezyme® (imiglucerase) should be carefully re-evaluated if there is significant clinical evidence of hypersensitivity to the product.
Last reviewed on RxList: 10/9/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Cerezyme Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Parenting and Pregnancy
Get tips for baby and you.